PFN Develops AI Drug Discovery Technology That Accelerates Initial Screening for Pharmaceutical Development

PFN Develops Precise 3D Pose Estimation Technology That Recognizes Finger Positions and Overlapped Hands

PFCC Launches Matlantis Atomistic Simulator as Cloud-Based Service

PFN’s MN-3 Tops Green500 List of World’s Most Energy-Efficient Supercomputers for Second Time

PFN Achieves Six-Fold Increase in Computational Speed for Deep Learning Workload with New Compiler for MN-Core Processor

Preferred Medicine Announces Presentation on Machine Learning-based Early Cancer Detections with Blood miRNAs at American Society of Clinical Oncology 2021

PFN and pixiv to Provide Automatic Manga Coloring Service to Companies on Trial Basis

PFN Appoints Prof. Ju Li of MIT as Technical Advisor

PFN to Conduct Joint Research with Nissin Food Products on Complete Nutrition Meals

PFN and ENEOS to Establish Joint Venture for Materials Discovery

Preferred Networks Releases CuPy v9

Curreio and PFN Collaborate on Drug Discovery Using Deep Learning and Structural Analysis